# Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata

> **NCT04003376** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 40 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DEVICE:** fractional carbon dioxide laser alone
- **DRUG:** Triamcinolone Acetonide 10mg/mL
- **BIOLOGICAL:** platelet rich plasma
- **DRUG:** vitamin D solution

## Key facts

- **NCT ID:** NCT04003376
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-26
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04003376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04003376, "Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04003376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*